A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock ... to escalate a patient's treatment to the shock pathway." ...
Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced that ...